Found: 13
Select item for more details and to access through your institution.
First-in-human study of DP303c, a HER2-targeted antibody-drug conjugate in patients with HER2 positive solid tumors.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00687-7
- By:
- Publication type:
- Article
Rh-endostatin combined with chemotherapy in patients with advanced or recurrent mucosal melanoma: retrospective analysis of real-world data.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 2, p. 453, doi. 10.1007/s10637-021-01172-9
- By:
- Publication type:
- Article
China's Low-Carbon Urbanization Progress and Pathway.
- Published in:
- Chinese Journal of Urban & Environmental Studies, 2015, v. 3, n. 4, p. -1, doi. 10.1142/S2345748115500281
- By:
- Publication type:
- Article
Phase I study of pucotenlimab (HX008), an anti-PD-1 antibody, for patients with advanced solid tumors.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211020528
- By:
- Publication type:
- Article
Synergistic antitumor effect of the anti-ErbB2 antibodies trastuzumab and H2-18 on trastuzumab-resistant gastric cancer cells.
- Published in:
- Oncology Letters, 2021, v. 21, n. 5, p. N.PAG, doi. 10.3892/ol.2021.12661
- By:
- Publication type:
- Article
Clinical characteristics and treatment outcomes of HER2 mutation and HER2 fusion in 22 patients with advanced breast cancer.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 34, p. 3381, doi. 10.1111/1759-7714.15130
- By:
- Publication type:
- Article
Phase I study of pucotenlimab (HX008), an anti-PD-1 antibody, for patients with advanced solid tumors.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211020528
- By:
- Publication type:
- Article
Epigenetic abnormalities of classical Hodgkin lymphoma and its effect on immune escape.
- Published in:
- Cell Biochemistry & Function, 2020, v. 38, n. 3, p. 242, doi. 10.1002/cbf.3463
- By:
- Publication type:
- Article
Enhanced CHOLESTEROL biosynthesis promotes breast cancer metastasis via modulating CCDC25 expression and neutrophil extracellular traps formation.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-22410-x
- By:
- Publication type:
- Article
Dalpiciclib Combined With Pyrotinib and Letrozole in Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer (LORDSHIPS): A Phase Ib Study.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Transit-Oriented Development in China: A Comparative Content Analysis of the Spatial Plans of High-Speed Railway Station Areas.
- Published in:
- Land (2012), 2023, v. 12, n. 9, p. 1818, doi. 10.3390/land12091818
- By:
- Publication type:
- Article
Phase I study of A166, an antibody‒drug conjugate in advanced HER2-expressing solid tumours.
- Published in:
- NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00522-5
- By:
- Publication type:
- Article
MicroRNA-143 targets MAPK3 to regulate the proliferation and bone metastasis of human breast cancer cells.
- Published in:
- AMB Express, 2020, v. 10, n. 1, p. 1, doi. 10.1186/s13568-020-01072-w
- By:
- Publication type:
- Article